StockWatch
·
Pharmaceuticals
Board Meeting29 Oct 2026, 08:40 pm

Sanjivani Paranteral Board Meeting on Nov 5 to Approve Q2 Un-Audited Results

AI Summary

Sanjivani Paranteral Ltd has announced that its Board of Directors will convene on November 5, 2026, to consider and approve the Un-Audited Financials for the Second Quarter ended September 30, 2026, along with the Limited Review Report. The meeting will also address any other business with the permission of the Chair and the consent of the majority of directors present, including at least one independent director. The approved results will be communicated after the meeting concludes.

Key Highlights

  • Board meeting scheduled for November 5, 2026.
  • To approve Un-Audited Financials for Q2 FY27.
  • Limited Review Report to be considered.
  • Includes any other business with director consent.